Christopher D. Pond

525 total citations
20 papers, 409 citations indexed

About

Christopher D. Pond is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Christopher D. Pond has authored 20 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Organic Chemistry and 5 papers in Pharmacology. Recurrent topics in Christopher D. Pond's work include Microbial Natural Products and Biosynthesis (4 papers), Cancer therapeutics and mechanisms (4 papers) and DNA Repair Mechanisms (2 papers). Christopher D. Pond is often cited by papers focused on Microbial Natural Products and Biosynthesis (4 papers), Cancer therapeutics and mechanisms (4 papers) and DNA Repair Mechanisms (2 papers). Christopher D. Pond collaborates with scholars based in United States, Papua New Guinea and Philippines. Christopher D. Pond's co-authors include Louis R. Barrows, Teatulohi Matainaho, Raymond L. Warters, Sancy A. Leachman, Michael Koch, Eric W. Schmidt, Chris M. Ireland, Ryan M. Van Wagoner, Mary Kay Harper and Tim S. Bugni and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Nature Chemical Biology.

In The Last Decade

Christopher D. Pond

20 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher D. Pond United States 10 214 146 89 87 46 20 409
Rhone K. Akee United States 10 253 1.2× 125 0.9× 139 1.6× 108 1.2× 28 0.6× 19 498
Pamela J. Schultz United States 12 327 1.5× 188 1.3× 115 1.3× 112 1.3× 46 1.0× 22 610
John J. Bowling United States 15 161 0.8× 107 0.7× 147 1.7× 157 1.8× 43 0.9× 27 461
Ki‐Hyeong Rhee South Korea 11 244 1.1× 109 0.7× 41 0.5× 51 0.6× 73 1.6× 23 485
Jehad Almaliti United States 13 320 1.5× 218 1.5× 99 1.1× 157 1.8× 32 0.7× 33 621
Yanan Qiao China 14 218 1.0× 139 1.0× 96 1.1× 78 0.9× 155 3.4× 42 563
Xuefu You China 16 251 1.2× 171 1.2× 147 1.7× 65 0.7× 53 1.2× 49 582
Jongkeun Choi South Korea 14 416 1.9× 76 0.5× 83 0.9× 41 0.5× 37 0.8× 34 642
Hideki Hashizume Japan 14 369 1.7× 207 1.4× 116 1.3× 77 0.9× 55 1.2× 25 591
Gráinne Abbott United Kingdom 10 118 0.6× 173 1.2× 76 0.9× 48 0.6× 63 1.4× 12 338

Countries citing papers authored by Christopher D. Pond

Since Specialization
Citations

This map shows the geographic impact of Christopher D. Pond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher D. Pond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher D. Pond more than expected).

Fields of papers citing papers by Christopher D. Pond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher D. Pond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher D. Pond. The network helps show where Christopher D. Pond may publish in the future.

Co-authorship network of co-authors of Christopher D. Pond

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher D. Pond. A scholar is included among the top collaborators of Christopher D. Pond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher D. Pond. Christopher D. Pond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yuan, Le, et al.. (2025). Open Enzyme Database: a community-wide repository for sharing enzyme data. Nucleic Acids Research. 54(D1). D643–D651. 2 indexed citations
2.
3.
Batista, Frederico M., James Lowther, Vera G. Fonseca, et al.. (2020). Whole Genome Sequencing of Hepatitis A Virus Using a PCR-Free Single-Molecule Nanopore Sequencing Approach. Frontiers in Microbiology. 11. 874–874. 16 indexed citations
4.
Pond, Christopher D., et al.. (2020). Pyrrolocin C and equisetin inhibit bacterial acetyl-CoA carboxylase. PLoS ONE. 15(5). e0233485–e0233485. 21 indexed citations
5.
Smith, Thomas E., Christopher D. Pond, Elizabeth Pierce, et al.. (2018). Accessing chemical diversity from the uncultivated symbionts of small marine animals. Nature Chemical Biology. 14(2). 179–185. 75 indexed citations
6.
Aknin, Maurice, Anne Gauvin‐Bialecki, Christopher D. Pond, et al.. (2017). Mollecarbamates, Molleureas, and Molledihydroisoquinolone, o-Carboxyphenethylamide Metabolites of the Ascidian Didemnum molle Collected in Madagascar. Journal of Natural Products. 80(6). 1844–1852. 8 indexed citations
7.
Pond, Christopher D., et al.. (2016). Traditional Preparations and Methanol Extracts of Medicinal Plants from Papua New Guinea Exhibit Similar Cytochrome P450 Inhibition. Evidence-based Complementary and Alternative Medicine. 2016(1). 7869710–7869710. 15 indexed citations
8.
Koch, Michael, Eric W. Schmidt, Anita M. Orendt, et al.. (2014). Isolation of Pyrrolocins A–C: cis- and trans-Decalin Tetramic Acid Antibiotics from an Endophytic Fungal-Derived Pathway. Journal of Natural Products. 77(11). 2537–2544. 33 indexed citations
9.
Jadulco, Raquel C., Christopher D. Pond, Ryan M. Van Wagoner, et al.. (2014). 4-Quinolone Alkaloids from Melochia odorata. Journal of Natural Products. 77(1). 183–187. 53 indexed citations
10.
Lin, Zhenjian, Michael Koch, Christopher D. Pond, et al.. (2013). Structure and activity of lobophorins from a turrid mollusk-associated Streptomyces sp. The Journal of Antibiotics. 67(1). 121–126. 35 indexed citations
11.
Lu, Zhenyu, Mary Kay Harper, Christopher D. Pond, et al.. (2012). Thiazoline Peptides and a Tris-Phenethyl Urea from Didemnum molle with Anti-HIV Activity. Journal of Natural Products. 75(8). 1436–1440. 32 indexed citations
12.
Jadulco, Raquel C., et al.. (2011). New Antimycobacterial Triterpenoids fromRhus taitensis. Planta Medica. 77(14). 1651–1654. 4 indexed citations
13.
Barrows, Louis R., Teatulohi Matainaho, Scott E. Miller, et al.. (2009). Making the most of Papua New Guinea’s biodiversity: Establishment of an integrated set of programs that link botanical survey with pharmacological assessment in “the land of the unexpected”. Pharmaceutical Biology. 47(8). 795–808. 6 indexed citations
14.
Barrows, Louis R., Chris M. Ireland, Michael Koch, et al.. (2008). Tetrahdroxysqualene from Rhus taitensis Shows Antimycobacterial Activity against Mycobacterium tuberculosis. Journal of Natural Products. 71(9). 1623–1624. 17 indexed citations
15.
Barrows, Louis R., et al.. (2007). Anti-TB activity of Evodia elleryana bark extract. Fitoterapia. 78(3). 250–252. 5 indexed citations
16.
Pond, Christopher D., Kathryn M. Marshall, & Louis R. Barrows. (2006). Identification of a small topoisomerase I–binding peptide that has synergistic antitumor activity with 9-aminocamptothecin. Molecular Cancer Therapeutics. 5(3). 739–745. 7 indexed citations
17.
Warters, Raymond L., et al.. (2005). Melanoma Cells Express Elevated Levels of Phosphorylated Histone H2AX Foci. Journal of Investigative Dermatology. 124(4). 807–817. 58 indexed citations
18.
Pond, Christopher D., Sancy A. Leachman, & Raymond L. Warters. (2004). Accumulation, Activation and Interindividual Variation of the Epidermal TP53 Protein in Response to Ionizing Radiation in Organ Cultured Human Skin. Radiation Research. 161(6). 739–745. 4 indexed citations
19.
20.
Pond, Christopher D., et al.. (1997). Surface plasmon resonance analysis of topoisomerase I-DNA binding: effect of Mg2+ and DNA sequence. Anti-Cancer Drugs. 8(4). 336–344. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rhone K. Akee Breakdown of academic impact, for papers by Pamela J. Schultz Breakdown of academic impact, for papers by John J. Bowling Breakdown of academic impact, for papers by Ki‐Hyeong Rhee Breakdown of academic impact, for papers by Jehad Almaliti Breakdown of academic impact, for papers by Yanan Qiao Breakdown of academic impact, for papers by Xuefu You Breakdown of academic impact, for papers by Jongkeun Choi Breakdown of academic impact, for papers by Hideki Hashizume Breakdown of academic impact, for papers by Gráinne Abbott
Rankless by CCL
2026